Clark Hill Member Gerald Schneeweis Published in DRI’s Drug and Medical Device Committee Rx for the Defense
Member Gerald Schneeweis’s article “On the Banks of the Stream of Commerce: Why There Should Be No Individual ‘Product’ Liability of Corporate Officers, Directors and Employees” was published today in the Defense Research Institute (DRI) Drug and Medical Device Committee’s Newsletter Rx for the Defense. In this article, Schneeweis describes the trend of plaintiffs to bring “product” liability claims against not only the company as an enterprise but also against corporate individuals and defends why some individuals should not be subject to individual “product” liability. To view the article, click here.
Schneeweis is a Member in Clark Hill’s Litigation practice group. He has represented pharmaceutical and medical device manufacturers, research entities and individual officers, directors and employees in product liability litigation asserting claims of design and manufacturing defect, failure to warn and off-label promotion. Schneeweis is a member of the DRI Drug & Medical Device Committee, the San Diego chapter of the American Board of Trial Advocates and the American Bar Association.
Religious Accommodations Update: What Manufacturers Need To KnowExplore more
Right To Know - November 30, 2022, Vol. 1
Cyber, Privacy, and Technology Report
FERC Advancing New Reliability Requirements for Renewables
The Federal Energy Regulatory Commission (FERC) recently issued two orders designed to address electric grid reliability implications raised by the dramatic growth in solar and wind projects. Renewable project owners and operators should follow these developments closely, as FERC’s orders propose to substantially increase registration and compliance requirements.